Associate Professor, Neurology, Georgetown University School of Medicine
Neurology
Dr. Robin A. Conwit, MD
Robin A. Conwit practices Neurology. He went to medical school at University at Buffalo, School of Medicine and Biomedical Sciences. Robin Conwit is a published doctor. He has 60 papers published. The most current publication "Firing rate analysis using decompostion-enhanced spike triggered averaging in the quadriceps femoris."
Publications
- Routing Ambulances to Designated Centers Increases Access to Stroke Center Care and Enrollment in Prehospital Research.
- Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population.
- Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
- Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
- Screen failure data in clinical trials: Are screening logs worth it?
- Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortica...
- Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 1 - rationale and general methods.
- Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 2 - prehospital study methods.
- Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial.
- Lessons from the RAMPART study-and which is the best route of administration of benzodiazepines in status epilepticus.
- Clinical Features and Racial/Ethnic Differences Among the 3020 Participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial.
- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: Rationale and design.
- Infrastructure resources for clinical research in amyotrophic lateral sclerosis.
- Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
- Biomarker development for myasthenia gravis.
- Adding more muscle and nerve to clinical trials.
- Age-associated changes in motor unit physiology: observations from the Baltimore Longitudinal Study of Aging.
- Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspective.
- Executive summary of the National Institute of Neurological Disorders and Stroke conference on Emergency Neurologic Clinical Trials Network.
- Executive summary: The Emergency Neurologic Clinical Trials Network meeting--a National Institute of Neurological Disorders and Stroke symposium.
- Arm-cranking muscle power and arm isometric muscle strength are independent predictors of all-cause mortality in men.
- Relationships between surface-detected EMG signals and motor unit activation.
- Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
- Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.
- Intramuscular versus intravenous therapy for prehospital status epilepticus.
- Implementing clinical trials on an international platform: challenges and perspectives.
- The Secondary Prevention of Small Subcortical Strokes (SPS3) study.
- Recruitment and retention of patients into emergency medicine clinical trials.
- Intercontinental elicitation of informed consent for enrollment in stroke research.
- Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA).
- Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials.
- RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenou...
- Skeletal muscle strength as a predictor of all-cause mortality in healthy men.
- Physiological correlates of age-related decline in vibrotactile sensitivity.
- The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.
- Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
- Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery.
- A 39-year-old man with hip pain and respiratory failure.
- Fatigue effects on motor unit activity during submaximal contractions.
- Weak and numb feet in a man with knobby hands.
- The relationship of motor unit size, firing rate and force.
- Decomposition-enhanced spike-triggered averaging: contraction level effects.
- Mixed nerve action potentials in acquired demyelinating polyneuropathy.
- Sensorimotor neuropathy resembling CIDP in patients receiving FK506.
- Relation of EEG alpha background to cognitive function, brain atrophy, and cerebral metabolism in Down's syndrome. Age-specific changes.
- Firing rate analysis using decompostion-enhanced spike triggered averaging in the quadriceps femoris.
- Ulnar nerve injury associated with removal of Norplant implants.
- Electromyographic patterns suggest changes in motor unit physiology associated with early osteoarthritis of the knee.
- Boosting enrolment in clinical trials: validation of a regional network model.
- Age-associated loss of power and strength in the upper extremities in women and men.
- Methods for estimating the numbers of motor units in human muscles.
- Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.
- Hyperkalemic periodic paralysis: rapid molecular diagnosis and relationship of genotype to phenotype in 12 families.
- Muscle quality and age: cross-sectional and longitudinal comparisons.
- The relationship of peripheral motor nerve conduction velocity to age-associated loss of grip strength.
- Neuroprotective agents for clinical trials in ALS: a systematic assessment.
- The relationship between ciliary neurotrophic factor (CNTF) genotype and motor unit physiology: preliminary studies.
- Preventing familial ALS: a clinical trial may be feasible but is an efficacy trial warranted?
- Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Schools
State University of New York At Buffalo
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
Education
-
University at Buffalo, School of Medicine and Biomedical Sciences
Helpful Reviews
Similar Doctors
|
Dr. Mark S. Godec, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny Z. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nina M. Seborowski, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thien T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taryn K. Fortune, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Konrad W. Bakker, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raul N. Mandler, MD
This Doctor is OpenDoctor Recommended.
|